• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用亚硝基胍在3D类器官中模拟胃小肠化生

Modeling gastric intestinal metaplasia in 3D organoids using nitrosoguanidine.

作者信息

Li Yuan, Chen Jiena, Li Tao, Lin Jie, Zheng Haocheng, Johnson Nadia, Yao Xuebiao, Ding Xia

机构信息

N ational Institute of Traditional Chinese Medicine Constitution and Preventive Treatment of Diseases, Beijing University of Chinese Medicine, Beijing 100029, China.

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.

出版信息

J Mol Cell Biol. 2024 Dec 20;16(7). doi: 10.1093/jmcb/mjae030.

DOI:10.1093/jmcb/mjae030
PMID:39153963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11744189/
Abstract

Gastric intestinal metaplasia (GIM) represents a precancerous stage characterized by morphological and pathophysiological changes in the gastric mucosa, where gastric epithelial cells transform into a phenotype resembling that of intestinal cells. Previous studies have demonstrated that the intragastric administration of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) induces both gastric carcinoma and intestinal metaplasia in mice. Here, we show that MNNG induces GIM in three-dimensional (3D) mouse organoids. Our histological analyses reveal that MNNG-induced gastric organoids undergo classical morphological alterations, exhibiting a distinct up-regulation of CDX2 and MUC2, along with a down-regulation of ATP4B and MUC6. Importantly, metaplastic cells observed in MNNG-treated organoids originate from MIST1+ cells, indicating their gastric chief cell lineage. Functional analyses show that activation of the RAS signaling pathway drives MNNG-induced metaplasia in 3D organoids, mirroring the characteristics observed in human GIM. Consequently, modeling intestinal metaplasia using 3D organoids offers valuable insights into the molecular mechanisms and spatiotemporal dynamics of the gastric epithelial lineage during the development of intestinal metaplasia within the gastric mucosa. We conclude that the MNNG-induced metaplasia model utilizing 3D organoids provides a robust platform for developing preventive and therapeutic strategies to mitigate the risk of gastric cancer before precancerous lesions occur.

摘要

胃黏膜肠化生(GIM)是一种癌前阶段,其特征是胃黏膜发生形态学和病理生理学变化,胃上皮细胞转变为类似肠细胞的表型。先前的研究表明,给小鼠胃内注射N-甲基-N'-硝基-N-亚硝基胍(MNNG)可诱导胃癌和肠化生。在此,我们表明MNNG可在三维(3D)小鼠类器官中诱导GIM。我们的组织学分析显示,MNNG诱导的胃类器官发生经典的形态学改变,表现为CDX2和MUC2明显上调,同时ATP4B和MUC6下调。重要的是,在MNNG处理的类器官中观察到的化生细胞起源于MIST1+细胞,表明它们来自胃主细胞谱系。功能分析表明,RAS信号通路的激活驱动MNNG诱导的3D类器官化生,这与在人类GIM中观察到的特征相似。因此,使用3D类器官模拟肠化生为深入了解胃黏膜内肠化生发展过程中胃上皮谱系的分子机制和时空动态提供了有价值的见解。我们得出结论,利用3D类器官的MNNG诱导化生模型为制定预防和治疗策略以降低癌前病变发生前胃癌风险提供了一个强大的平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/d8b3f36abb3a/mjae030fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/fddf78145afd/mjae030fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/ea0c33a300f9/mjae030fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/936d1fa62d31/mjae030fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/726728f724fe/mjae030fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/a3eb12f6d2f4/mjae030fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/d8b3f36abb3a/mjae030fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/fddf78145afd/mjae030fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/ea0c33a300f9/mjae030fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/936d1fa62d31/mjae030fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/726728f724fe/mjae030fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/a3eb12f6d2f4/mjae030fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10fa/11744189/d8b3f36abb3a/mjae030fig6.jpg

相似文献

1
Modeling gastric intestinal metaplasia in 3D organoids using nitrosoguanidine.使用亚硝基胍在3D类器官中模拟胃小肠化生
J Mol Cell Biol. 2024 Dec 20;16(7). doi: 10.1093/jmcb/mjae030.
2
The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats.黄芪甲苷对 MNNG 致 GPL 大鼠胃黏膜的保护作用。
Biomed Pharmacother. 2018 Aug;104:291-299. doi: 10.1016/j.biopha.2018.04.013. Epub 2018 May 25.
3
Wei-fu-chun tablet halted gastric intestinal metaplasia and dysplasia associated with inflammation by regulating the NF-κB pathway.胃复春片通过调控 NF-κB 通路抑制炎症相关的胃黏膜肠上皮化生及异型增生。
J Ethnopharmacol. 2024 Jan 10;318(Pt B):117020. doi: 10.1016/j.jep.2023.117020. Epub 2023 Aug 9.
4
Comparison of stomach cancer induced in rats by N-methyl-N'-nitro-N-nitrosoguanidine or N-propyl-N'-nitro-N-nitrosoguanidine.N-甲基-N'-硝基-N-亚硝基胍或N-丙基-N'-硝基-N-亚硝基胍诱导大鼠胃癌的比较。
Cancer Lett. 1987 Feb;34(2):173-85. doi: 10.1016/0304-3835(87)90008-5.
5
Relationship between gastric tumorigenesis and intestinal metaplasia in rats given x-radiation and/or N-methyl-N'-nitro-N-nitrosoguanidine.接受X射线和/或N-甲基-N'-硝基-N-亚硝基胍处理的大鼠胃肿瘤发生与肠化生之间的关系
J Natl Cancer Inst. 1986 May;76(5):865-70.
6
Induction of intestinal metaplasia in the stomachs of rats by N-methyl-N'-nitro-N-nitrosoguanidine.用N-甲基-N'-硝基-N-亚硝基胍诱导大鼠胃黏膜肠化生
J Natl Cancer Inst. 1978 Jul;61(1):141-4. doi: 10.1093/jnci/61.1.141.
7
Induction of intestinal metaplasia in the glandular stomach of rats by X-irradiation prior to oral administration of N-methyl-N'-nitro-N-nitrosoguanidine.在口服N-甲基-N'-硝基-N-亚硝基胍之前,通过X射线照射诱导大鼠腺胃肠化生。
Gan. 1980 Dec;71(6):804-10.
8
Alkaline phosphatase isoenzymes in intestinal metaplasia and carcinoma of rat stomach induced by N-methyl-N'-nitro-N-nitrosoguanidine.N-甲基-N'-硝基-N-亚硝基胍诱导的大鼠胃肠化生和癌中的碱性磷酸酶同工酶
Oncodev Biol Med. 1980;1(4-5):313-23.
9
Effects of Granule Dendrobii on chronic atrophic gastritis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats.颗粒石斛对大鼠 N-甲基-N'-硝基-N-亚硝基胍诱导的慢性萎缩性胃炎的影响。
World J Gastroenterol. 2022 Aug 28;28(32):4668-4680. doi: 10.3748/wjg.v28.i32.4668.
10
Revealing the pathogenesis of gastric intestinal metaplasia based on the mucosoid air-liquid interface.基于黏膜样气液界面揭示胃肠化生的发病机制。
J Transl Med. 2024 May 17;22(1):468. doi: 10.1186/s12967-024-05276-7.

本文引用的文献

1
Chromosomal fragile site breakage by EBV-encoded EBNA1 at clustered repeats.EBV 编码的 EBNA1 在簇状重复序列处导致染色体脆性位点断裂。
Nature. 2023 Apr;616(7957):504-509. doi: 10.1038/s41586-023-05923-x. Epub 2023 Apr 12.
2
Rho activation drives luminal collapse and eversion in epithelial acini.Rho 激活驱动上皮腺泡腔的塌陷和翻转。
Biophys J. 2023 Sep 19;122(18):3630-3645. doi: 10.1016/j.bpj.2023.01.005. Epub 2023 Jan 7.
3
Anti-tumor efficacy of a potent and selective non-covalent KRAS inhibitor.一种强效且选择性的非共价 KRAS 抑制剂的抗肿瘤功效。
Nat Med. 2022 Oct;28(10):2171-2182. doi: 10.1038/s41591-022-02007-7. Epub 2022 Oct 10.
4
CDX2-induced intestinal metaplasia in human gastric organoids derived from induced pluripotent stem cells.CDX2诱导源自诱导多能干细胞的人胃类器官发生肠化生。
iScience. 2022 Apr 28;25(5):104314. doi: 10.1016/j.isci.2022.104314. eCollection 2022 May 20.
5
BRAF Mutation Is Associated with Hyperplastic Polyp-Associated Gastric Cancer.BRAF 突变与增生性息肉相关的胃癌相关。
Int J Mol Sci. 2021 Nov 25;22(23):12724. doi: 10.3390/ijms222312724.
6
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer.致癌性 KRAS 在结直肠癌的预后、诊断和治疗中的作用。
Mol Cancer. 2021 Nov 6;20(1):143. doi: 10.1186/s12943-021-01441-4.
7
Dynamic crotonylation of EB1 by TIP60 ensures accurate spindle positioning in mitosis.TIP60介导的EB1动态巴豆酰化确保有丝分裂中纺锤体的精确定位。
Nat Chem Biol. 2021 Dec;17(12):1314-1323. doi: 10.1038/s41589-021-00875-7. Epub 2021 Oct 4.
8
Chief cell plasticity is the origin of metaplasia following acute injury in the stomach mucosa.主细胞可塑性是胃黏膜急性损伤后化生的起源。
Gut. 2022 Jun;71(6):1068-1077. doi: 10.1136/gutjnl-2021-325310. Epub 2021 Sep 8.
9
Modeling Gastrointestinal Diseases Using Organoids to Understand Healing and Regenerative Processes.利用类器官模型研究胃肠道疾病,以了解愈合和再生过程。
Cells. 2021 May 27;10(6):1331. doi: 10.3390/cells10061331.
10
Gastric cancer.胃癌。
Lancet. 2020 Aug 29;396(10251):635-648. doi: 10.1016/S0140-6736(20)31288-5.